Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings… Read more
Intuitive Surgical Inc (ISRG) - Net Assets
Latest net assets as of December 2025: $17.94 Billion USD
Based on the latest financial reports, Intuitive Surgical Inc (ISRG) has net assets worth $17.94 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($20.63 Billion) and total liabilities ($2.69 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $17.94 Billion |
| % of Total Assets | 86.96% |
| Annual Growth Rate | 27.44% |
| 5-Year Change | 50.12% |
| 10-Year Change | 210.53% |
| Growth Volatility | 82.49 |
Intuitive Surgical Inc - Net Assets Trend (1998–2025)
This chart illustrates how Intuitive Surgical Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Intuitive Surgical Inc (1998–2025)
The table below shows the annual net assets of Intuitive Surgical Inc from 1998 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $17.94 Billion | +8.54% |
| 2024-12-31 | $16.53 Billion | +23.38% |
| 2023-12-31 | $13.40 Billion | +20.56% |
| 2022-12-31 | $11.11 Billion | -7.02% |
| 2021-12-31 | $11.95 Billion | +22.47% |
| 2020-12-31 | $9.76 Billion | +17.80% |
| 2019-12-31 | $8.28 Billion | +23.88% |
| 2018-12-31 | $6.69 Billion | +41.48% |
| 2017-12-31 | $4.73 Billion | -18.19% |
| 2016-12-31 | $5.78 Billion | +33.76% |
| 2015-12-31 | $4.32 Billion | +27.82% |
| 2014-12-31 | $3.38 Billion | -3.48% |
| 2013-12-31 | $3.50 Billion | -2.20% |
| 2012-12-31 | $3.58 Billion | +35.32% |
| 2011-12-31 | $2.65 Billion | +29.85% |
| 2010-12-31 | $2.04 Billion | +32.53% |
| 2009-12-31 | $1.54 Billion | +21.35% |
| 2008-12-31 | $1.27 Billion | +42.55% |
| 2007-12-31 | $888.67 Million | +50.70% |
| 2006-12-31 | $589.71 Million | +33.24% |
| 2005-12-31 | $442.59 Million | +40.54% |
| 2004-12-31 | $314.93 Million | +12.90% |
| 2003-12-31 | $278.96 Million | +338.06% |
| 2002-12-31 | $63.68 Million | -18.66% |
| 2001-12-31 | $78.29 Million | -13.71% |
| 2000-12-31 | $90.73 Million | +308.49% |
| 1999-12-31 | $22.21 Million | -13.67% |
| 1998-12-31 | $25.73 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Intuitive Surgical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 706853200000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $7.01 Billion | 39.34% |
| Common Stock | $400.00K | 0.00% |
| Other Comprehensive Income | $43.30 Million | 0.24% |
| Other Components | $10.77 Billion | 60.42% |
| Total Equity | $17.82 Billion | 100.00% |
Intuitive Surgical Inc Competitors by Market Cap
The table below lists competitors of Intuitive Surgical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
The TJX Companies Inc
NYSE:TJX
|
$171.90 Billion |
|
HSBC Holdings PLC
PINK:HBCYF
|
$173.52 Billion |
|
Walt Disney Company
NYSE:DIS
|
$174.52 Billion |
|
Novo Nordisk A/S
PINK:NONOF
|
$175.04 Billion |
|
Ping An Insurance Company of China
PINK:PNGAY
|
$168.25 Billion |
|
Amphenol Corporation
NYSE:APH
|
$167.08 Billion |
|
Verizon Communications Inc
NYSE:VZ
|
$164.48 Billion |
|
The Boeing Company
NYSE:BA
|
$160.85 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Intuitive Surgical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 16,433,700,000 to 17,824,000,000, a change of 1,390,300,000 (8.5%).
- Net income of 2,856,000,000 contributed positively to equity growth.
- Share repurchases of 2,295,300,000 reduced equity.
- Other comprehensive income increased equity by 94,600,000.
- Other factors increased equity by 735,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.86 Billion | +16.02% |
| Share Repurchases | $2.30 Billion | -12.88% |
| Other Comprehensive Income | $94.60 Million | +0.53% |
| Other Changes | $735.00 Million | +4.12% |
| Total Change | $- | 8.46% |
Book Value vs Market Value Analysis
This analysis compares Intuitive Surgical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.84x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 1911.39x to 9.84x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $0.25 | $483.46 | x |
| 1999-12-31 | $0.20 | $483.46 | x |
| 2000-12-31 | $0.85 | $483.46 | x |
| 2001-12-31 | $0.49 | $483.46 | x |
| 2002-12-31 | $0.39 | $483.46 | x |
| 2003-12-31 | $1.31 | $483.46 | x |
| 2004-12-31 | $1.00 | $483.46 | x |
| 2005-12-31 | $1.31 | $483.46 | x |
| 2006-12-31 | $1.72 | $483.46 | x |
| 2007-12-31 | $2.53 | $483.46 | x |
| 2008-12-31 | $3.52 | $483.46 | x |
| 2009-12-31 | $4.36 | $483.46 | x |
| 2010-12-31 | $5.62 | $483.46 | x |
| 2011-12-31 | $7.31 | $483.46 | x |
| 2012-12-31 | $9.68 | $483.46 | x |
| 2013-12-31 | $9.70 | $483.46 | x |
| 2014-12-31 | $9.96 | $483.46 | x |
| 2015-12-31 | $12.66 | $483.46 | x |
| 2016-12-31 | $16.34 | $483.46 | x |
| 2017-12-31 | $13.55 | $483.46 | x |
| 2018-12-31 | $18.74 | $483.46 | x |
| 2019-12-31 | $23.11 | $483.46 | x |
| 2020-12-31 | $27.04 | $483.46 | x |
| 2021-12-31 | $32.67 | $483.46 | x |
| 2022-12-31 | $30.50 | $483.46 | x |
| 2023-12-31 | $37.23 | $483.46 | x |
| 2024-12-31 | $45.40 | $483.46 | x |
| 2025-12-31 | $49.14 | $483.46 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Intuitive Surgical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.02%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 28.38%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 1.16x
- Recent ROE (16.02%) is above the historical average (1.09%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | -142.95% | 0.00% | 0.00x | 1.37x | $-31.50 Million |
| 1999 | -82.91% | -180.68% | 0.30x | 1.55x | $-20.64 Million |
| 2000 | -20.42% | -69.57% | 0.24x | 1.24x | $-27.60 Million |
| 2001 | -21.33% | -32.32% | 0.51x | 1.28x | $-24.53 Million |
| 2002 | -28.93% | -25.58% | 0.79x | 1.44x | $-24.79 Million |
| 2003 | -3.45% | -10.50% | 0.29x | 1.13x | $-37.52 Million |
| 2004 | 7.45% | 16.91% | 0.39x | 1.12x | $-8.02 Million |
| 2005 | 21.27% | 41.41% | 0.45x | 1.13x | $49.87 Million |
| 2006 | 12.22% | 19.33% | 0.55x | 1.14x | $13.07 Million |
| 2007 | 16.26% | 24.06% | 0.58x | 1.17x | $55.67 Million |
| 2008 | 16.13% | 23.35% | 0.59x | 1.16x | $77.64 Million |
| 2009 | 15.13% | 22.11% | 0.58x | 1.18x | $78.88 Million |
| 2010 | 18.74% | 27.02% | 0.59x | 1.17x | $178.06 Million |
| 2011 | 18.71% | 28.17% | 0.57x | 1.16x | $230.54 Million |
| 2012 | 18.34% | 30.14% | 0.54x | 1.13x | $298.59 Million |
| 2013 | 19.16% | 29.62% | 0.57x | 1.13x | $320.86 Million |
| 2014 | 12.39% | 19.65% | 0.54x | 1.17x | $80.86 Million |
| 2015 | 13.63% | 24.69% | 0.49x | 1.14x | $156.85 Million |
| 2016 | 12.74% | 27.21% | 0.42x | 1.12x | $158.12 Million |
| 2017 | 13.96% | 21.09% | 0.54x | 1.22x | $187.32 Million |
| 2018 | 16.89% | 30.29% | 0.47x | 1.17x | $460.02 Million |
| 2019 | 16.65% | 30.80% | 0.46x | 1.17x | $550.83 Million |
| 2020 | 10.87% | 24.33% | 0.39x | 1.14x | $84.69 Million |
| 2021 | 14.26% | 29.85% | 0.42x | 1.13x | $509.45 Million |
| 2022 | 11.98% | 21.25% | 0.48x | 1.17x | $218.11 Million |
| 2023 | 13.51% | 25.24% | 0.46x | 1.16x | $467.24 Million |
| 2024 | 14.13% | 27.81% | 0.44x | 1.15x | $679.23 Million |
| 2025 | 16.02% | 28.38% | 0.49x | 1.16x | $1.07 Billion |
Industry Comparison
This section compares Intuitive Surgical Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,344,700,045
- Average return on equity (ROE) among peers: -67.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Intuitive Surgical Inc (ISRG) | $17.94 Billion | -142.95% | 0.15x | $170.64 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $520.03 Million | 8.62% | 0.25x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $121.35 Million | -35.38% | 0.57x | $16.24 Million |
| Alcon AG (ALC) | $18.82 Billion | -2.82% | 0.47x | $37.83 Billion |
| Align Technology Inc (ALGN) | $93.44 Million | 1.51% | 0.52x | $11.30 Billion |
| AngioDynamics Inc (ANGO) | $405.75 Million | 2.00% | 0.08x | $353.07 Million |
| Ansell Limited (ANSLF) | $1.40 Billion | 7.95% | 0.69x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.24 Billion |
| AtriCure Inc (ATRC) | $15.61 Million | -34.94% | 1.17x | $1.46 Billion |
| Avinger Inc (AVGR) | $-6.20 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $1.86 Million | -634.53% | 4.26x | $156.14 Million |